Related Experiment Videos
[Pathophysiology and clinical manifestations in pre-eclampsia]
Insights
Preeclampsia, a disorder of pregnancy, involves placental dysfunction leading to maternal and fetal complications. Understanding its pathophysiology, including lipid peroxidation and genetic factors, is key to developing new treatments.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Pathophysiology
Context:
- Preeclampsia is a serious pregnancy complication characterized by hypertension and proteinuria.
- Evidence suggests a genetic predisposition and placental pathology as central to preeclampsia.
- Existing literature reviews highlight the need for deeper understanding of preeclampsia's mechanisms.
Purpose:
- To review the current understanding of preeclampsia's pathophysiology.
- To synthesize findings on placental dysfunction, endothelial damage, and metabolic factors in preeclampsia.
- To explore the role of genetic factors and coagulation abnormalities in severe and early-onset preeclampsia.
Summary:
- Defective placental development and invasion of spiral arteries lead to poor placental perfusion, hypoxia, and cytokine release, causing endothelial dysfunction.
- Elevated triglyceride-rich lipoproteins and lipid peroxidation, originating partly from the placenta, contribute to endothelial damage and preeclampsia.
- Factors such as antioxidant deficiency, hyperhomocysteinemia, and deficiencies/resistance in proteins S and C are implicated in severe and early-onset preeclampsia.
Impact:
- Advances in understanding preeclampsia pathophysiology can inform the development of novel therapeutic strategies.
- This review provides a foundation for future research into targeted treatments for preeclampsia.
- Improved knowledge of preeclampsia mechanisms may lead to better patient outcomes and reduced maternal-fetal morbidity.
Background:
Preeclampsia is a progressive, multisystem disorder characterised by hypertension and proteinuria. A body of evidence suggest a genetic basis; it is generally accepted that the underlying pathological processes are in the placenta.
Material And Methods:
This article is a review of the pathophysiology of preeclampsia based on literature mainly obtained through PubMed and Medline searches.
Results:
A poorly perfused placenta, secondary to defective placental invasion of the spiral arteries, may lead to hypoxia and insufficient perfusion and cause release of cytokines which damage endothelial cells and cause dysfunction. Women with preeclampsia have markedly elevated concentrations of triglyceride-rich lipoproteins. Lipid peroxidation also causes endothelial dysfunction and thus contributes to preeclampsia. Placenta is one source of the lipid peroxides. Antioxidant deficiency is also a predisposing factor. Hyperhomocysteinaemia, protein S and protein C deficiency, and activated protein C resistance appear to be involved in the pathophysiology of severe preeclampsia and early onset preeclampsia.
Interpretation:
The new information about mechanisms for development of preeclampsia gives a basis for new treatment modalities.